Dynavax to Present at the William Blair 2014 Growth Stock Conference
BERKELEY, CA -- (Marketwired) -- 06/09/14 -- Dynavax Technologies
Corporation (NASDAQ: DVAX) announced today that it will present at
the William Blair 2014 Growth Stock Conference in Chicago on
Wednesday, June 11, 2014 at 2:40 p.m. Central Time (12:40 p.m.
Eddie Gray, Chief Executive Officer of Dynavax, will provide a
company overview. To access the slide presentation, live webcast, and
subsequent archived recording, please visit Dynavax's website at
Dynavax, a clinical-stage biopharmaceutical company, discovers and
develops novel vaccines and therapeutics in the areas of infectious
and inflammatory diseases and oncology. Dynavax's lead product
candidate is HEPLISAV-B(TM), a Phase 3 investigational adult
hepatitis B vaccine. For more information visit www.dynavax.com.
Chief Business and Principal Financial Officer
Press spacebar to pause and continue. Press esc to stop.